HIV and Rare Opportunistic Infections: Immune Mechanisms and Prevention
Why HIV Increases Rare Disease Susceptibility
HIV depletes CD4+ T‑helper cells, crippling cell‑mediated immunity and humoral coordination. As CD4 count falls (<200 cells/µL), opportunistic infections (OIs) emerge.
Key Factors
- Opportunistic infections: Pneumocystis jirovecii pneumonia (PCP), cytomegalovirus (CMV), cryptococcal meningitis, toxoplasmosis, Mycobacterium avium complex (MAC), Kaposi sarcoma (HHV‑8).
- Impaired antibody production: Reduced response to new antigens and vaccines.
- High viral load: Direct immune activation and exhaustion.
- Co‑infections: HBV, HCV, STIs accelerate immune decline.
- Chronic immune activation: Persistent inflammation drives non‑AIDS comorbidities (CVD, neurocognitive decline).
Prevention and Management
- Early ART initiation (treat all regardless of CD4).
- OI prophylaxis per CD4 thresholds (e.g., TMP‑SMX for PCP <200).
- Vaccinations (inactivated preferred).
- Regular monitoring (CD4, viral load, renal/hepatic function).
- Screening/treatment for co‑infections.
HIV & AIDS - Related Articles
- Exploring Complementary Therapies for HIV Symptom Management
- HIV/AIDS in Malawi: Impact and Prevention
- HIV Treatment: ART, PrEP, PEP, and Comprehensive Care
- Benefits of Technological Aids: Efficiency, Accuracy, Accessibility, and Innovation
- HIV Transmission: Can Sharing Shoes Spread the Virus?
- HIV Vaccine Development: Current Status, Challenges, and Hope
- HIV Treatment Is Based on Science, Not Faith: Medical Consensus
